A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia

PHASE3CompletedINTERVENTIONAL
Enrollment

969

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Nosocomial Pneumonia (NP)Ventilator-associated Pneumonia (VAP)
Interventions
DRUG

ceftazidim-avibactam (CAZ-AVI, experimental product)

2000mg ceftazidime plus 500mg avibactam

DRUG

meropenem (active comparator)

1000mg of Meropenem

Trial Locations (123)

Unknown

Research Site, Chongqing

Research Site, Guangzhou

Research Site, Haikou

Research Site, Hangzhou

Research Site, Jiangyin

Research Site, Nanchang

Research Site, Qingdao

Research Site, Sanya

Research Site, Shanghai

Research Site, Shenyang

Research Site, Shenzhen

Research Site, Suzhou

Research Site, Tianjin

Research Site, Xi'an

Research Site, Xiamen

Research Site, Yangzhou

Research Site, Zhanjiang

Research Site, Kolín

Research Site, Kyjov

Research Site, Praha 10, Prague

Research Site, Limoges

Research Site, Nantes

Research Site, Paris

Research Site, Pierre-Bénite

Research Site, Poitiers

Research Site, Strasbourg

Research Site, Tours

Research Site, Budapest

Research Site, Miskolc

Research Site, Székesfehérvár

Research Site, Veszprém

Research Site, Bangalore

Research Site, Jaipur

Research Site, Lucknow

Research Site, Pune

Research Site, Varanasi

Research Site, Bologna

Research Site, Fukuoka

Research Site, Higashiibaraki-gun

Research Site, Ikeda-shi

Research Site, Itabashi-ku

Research Site, Izumo-shi

Research Site, Kagoshima

Research Site, Kawasaki-shi

Research Site, Kitakyushu-shi

Research Site, Kushiro

Research Site, Matsuyama

Research Site, Osaka

Research Site, Saga

Research Site, Sapporo

Research Site, Sasebo-shi

Research Site, Tsuchiura-shi

Research Site, Tsukubo-gun

Research Site, Uji-shi

Research Site, Uki-shi

Research Site, Yanai-shi

Research Site, Liepāja

Research Site, Guadalajara

Research Site, Monterrey

Research Site, Cusco

Research Site, Lima

Research Site, Iloilo City

Research Site, Quezon City

Research Site, Bydgoszcz

Research Site, Chrzanów

Research Site, Lublin

Research Site, Olsztyn

Research Site, Proszowice

Research Site, Suwałki

Research Site, Łęczna

Research Site, Craiova

Research Site, Timișoara

Research Site, Arkhangelsk

Research Site, Chelyabinsk

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Smolensk

Research Site, Zelenograd

Research Site, Golnik

Research Site, Randburg

Research Site, Ansan-si

Research Site, Anyang-si

Research Site, Incheon

Research Site, Jinju

Research Site, Seoul

Research Site, Wŏnju

Research Site, Barcelona

Research Site, Madrid

Research Site, Sabadell(Barcelona)

Research Site, Terrassa (Barcelona)

Research Site, Taichung

Research Site, Ankara

Research Site, Dnipropetrovsk

Research Site, Donetsk

Research Site, Ivano-Frankivsk

Research Site, Kharkiv

Research Site, Kyiv

Research Site, Mykolayiv

Research Site, Poltava

Research Site, Vinnytsia

Research Site, Birmingham

Research Site, Blackpool

Research Site, Guildford

Research Site, Hull

Research Site, Hanoi

Research Site, Ho Chi Minh City

Research Site, Hochiminh

Research Site, Buenos Aires

Research Site, Córdoba

Research Site, Florida

Research Site, La Plata

Research Site, Mendoza

Research Site, Belo Horizonte

Research Site, Campinas/SP

Research Site, Curitiba

Research Site, São José do Rio Preto

Research Site, Burgas

Research Site, Plovdiv

Research Site, Rousse

Research Site, Sofia

Research Site, Beijing

Research Site, Changsha

Research Site, Chengdu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01808092 - A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia | Biotech Hunter | Biotech Hunter